This inventor holds 3 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignees: Université D'auvergne Clermont 1, National Institute of Health and Medical Research, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4 
2 out of 1,853 
1 out of 8,827 
Years Active: 2013-2019
Title: Innovator Spotlight: Jean-Michel Chezal
Introduction
Jean-Michel Chezal is a distinguished inventor based in Clermont-Ferrand, France, recognized for his significant contributions to the field of medical imaging and pharmaceutical innovations. With a portfolio boasting three patents, his work emphasizes the development of advanced imaging agents and multimodal radiopharmaceuticals.
Latest Patents
Jean-Michel Chezal's most notable patents include:
1. Macrocyclic complexes, their process of preparation and use as PET imaging agents. This invention focuses on innovative compounds of formula (I), detailing their preparation processes and potential applications as diagnostic agents in PET imaging.
2. Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors. This invention pertains to specific compounds of formula (I), alongside pharmaceutical compositions that facilitate their use in diagnostic applications, particularly using SPECT or PET imaging, as well as targeted radionuclide therapy for melanoma.
Career Highlights
Throughout his career, Jean-Michel Chezal has made impactful strides in the realms of research and development. He has been affiliated with influential institutions such as Université d'Auvergne Clermont 1 and Inserm (Institut National de la Santé et de la Recherche Médicale), where he has engaged in pioneering research.
Collaborations
Jean-Michel has collaborated with esteemed colleagues, including Vincent Gaumet and Jean-Claude Madelmont. Their collective efforts have contributed to advancing the understanding and application of radiopharmaceuticals in medical diagnostics and therapies.
Conclusion
Jean-Michel Chezal exemplifies innovation within the fields of medical imaging and pharmaceuticals. His dedication to developing cutting-edge technologies and collaborating with leading experts highlights the importance of teamwork in advancing scientific knowledge and improving patient care. As he continues to innovate, his contributions will undoubtedly pave the way for future discoveries in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile